News

The UK Technology Strategy Board (TSB) will invest £39.5 million across six calls in the next six months, in areas from regenerative medicine to low carbon housing.

The Alsace BioValley cluster has launched SHIP-In, a project to develop induced pluripotent stem cells for use in drug discovery.

The commercial imperative is undermining basic research and threatening the university ethos according to an independent body, says a new report.

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

The central priority of the EU’s new Innovation Policy should be utilising research “rapidly and powerfully” for societal and development benefit, say business leaders in a new report.

Two Framework Programme 6 (FP6) schemes specifically devised to promote the development of the European Research Area failed to deliver, according to a new report.

Venture capitalists are once again taking a shine to Cleantech, emboldened by the highly successful IPO of a battery company and huge amounts of stimulus funding.

The new Karlsruhe Institute of Technology is the most dramatic example of Germany's attempt to break down walls within academia.

Science|Business speaks to Professor Matthias Kleiner, President of the Deutsche Forschungsgemeinschaft, about the impact of the Excellence Initiative on German higher education.